NeuroPace Inc. has secured $49 million in venture capital funding that could end up being as much as $61.9 million, according to a regulatory filing on Tuesday.
The Mountain View-based company specializes in implantable devices for treating neurological disorders by responsive brain stimulation.
No comments:
Post a Comment